Indian Immunologicals Limited

𝗠𝗲𝗲𝘁 𝗜𝗜𝗟 𝗮𝘁 𝗪𝗼𝗿𝗹𝗱 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 (𝗪𝗮𝘀𝗵𝗶𝗻𝗴𝘁𝗼𝗻, 𝗨𝗦𝗔) We’re excited to share that 𝗜𝗜𝗟 𝘄𝗶𝗹𝗹 𝗯𝗲 𝗲𝘅𝗵𝗶𝗯𝗶𝘁𝗶𝗻𝗴 𝗮𝘁 𝘁𝗵𝗲 𝗪𝗼𝗿𝗹𝗱 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗶𝗻 𝗪𝗮𝘀𝗵𝗶𝗻𝗴𝘁𝗼𝗻, 𝗨𝗦𝗔 𝗮𝘁 𝘁𝗵𝗲 𝗜𝗻𝗱𝗶𝗮 𝗣𝗮𝘃𝗶𝗹𝗹𝗶𝗼𝗻. — connecting with thriving vaccine industry key stakeholders. Our Managing Director 𝗗𝗿 𝗔𝗻𝗮𝗻𝗱 𝗞𝘂𝗺𝗮𝗿 and Sr Vice President - International Business, 𝗦𝗮𝗿𝘁𝗵𝗮𝗸 𝗩𝗮𝘀𝘂𝗱𝗲𝘃𝗮 shall be representing the company at the event. Our 𝗠𝗗, 𝗗𝗿 𝗔𝗻𝗮𝗻𝗱 𝗞𝘂𝗺𝗮𝗿 will be part of the panel discussion on “𝗧𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗻𝗴 𝗣𝘂𝗯𝗹𝗶𝗰 𝗥&𝗗 𝗶𝗻𝘁𝗼 𝗔𝗻𝗶𝗺𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻.” 𝗼𝗻 𝟭𝘀𝘁 𝗔𝗽𝗿'𝟮𝟲. If you’re attending WVC and exploring collaboration opportunities, we’d love to connect. Companies can reach out to IIL to: 𝗮) 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 & 𝗹𝗶𝗰𝗲𝗻𝘀𝗶𝗻𝗴 Discuss 𝗲𝗮𝗿𝗹𝘆-𝘀𝘁𝗮𝗴𝗲 𝗰𝗮𝗻𝗱𝗶𝗱𝗮𝘁𝗲𝘀 for 𝗰𝗼-𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 and 𝗹𝗶𝗰𝗲𝗻𝘀𝗶𝗻𝗴 pathways. 𝗯) 𝗖𝗼𝗻𝘁𝗿𝗮𝗰𝘁 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽𝘀 Leverage IIL’s 𝘀𝗰𝗮𝗹𝗲 𝗼𝗳 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴, 𝗰𝗼𝘀𝘁 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲𝗻𝗲𝘀𝘀, 𝗼𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆, 𝗮𝗻𝗱 𝘀𝘁𝗿𝗼𝗻𝗴 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲—especially where these strengths create a compelling case for your candidate’s manufacturing strategy. 𝗰) 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝗿𝗲𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 Explore partnerships for 𝗿𝗲𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗶𝗻𝗴 𝗜𝗜𝗟’𝘀 𝗰𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹𝗹𝘆 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝘃𝗮𝗰𝗰𝗶𝗻𝗲𝘀 in relevant markets. #WorldVaccineCongress #HumanHealth #AnimalHealth #Vaccines #Licensing #CDMO #Biomanufacturing

Our MD, Dr. Anand Kumar hosted Shri. Vijay Nehra, Joint Secretary, Ministry of Health and Family Welfare (@MoHFW_INDIA), Government of India and Chairman, HLL Biotech Ltd at our Gachibowli manufacturing facility. Senior officials from both sides discussed about possible collaborative opportunities in the field of vaccine. It is pertinent to note that IIL has been a trusted and one of the largest supplier of human vaccines to the Universal Immunization Programme (UIP) run by Government of India for many years. Pentavalent vaccine, Measles-Rubella vaccine, DTP vaccine, Recombinant Hepatitis B vaccine are some of the major vaccines supplied. We are fortunate to live in a country wherein our Government procures life saving vaccines and provides it to all citizens free of cost. @NDDB_Coop

Road to Anand: Reflections of a Contented Soul - written by Dr. K. Anand Kumar. The book explores themes of resilience, leadership, purpose, and the pursuit of inner contentment, encouraging readers—especially young leaders—to view adversity as a catalyst for growth and meaningful success. Chapter 26 of the book: Not longing for long hours Click on the link to read the news article by Express Pharma: expresspharma.in/road-to-anand-…

It is with pride to let know that our Managing Director, Dr.K.Anand Kumar has been conferred with the Dr.Verghese Kurien Memorial Award and Citation by Pt.Deen Dayal Upadhayaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go Anusandhan Sansthan, Mathura. The award was presented by Dr. Abhijit Mitra, Vice Chancellor of esteemed University in the presence of Deans of various institutions, staff and several hundred students from the disciplines of veterinary sciences, fishery sciences, biotechnology etc. Dr. Kumar spoke about the Visionary leader Dr.Kurien who decades ago addressed the top three goals of the modern SDGs, No poverty, Zero hunger, Good health and Well being. All this through creation of many institutions of importance including the creation of IIL in 1982. @NDDB_Coop

Proud to share that Indian Immunologicals Ltd is exhibiting at World Vaccine Congress Washington 2026 on 30 March – 2 April. This event brings together decision-makers, innovators, and solution providers shaping the future of vaccines. Join us in Washington. Extra 25% off with code SBEXH25 + 20% early-bird discount until 6 March. 👉 Register now: i.snoball.it/p/4k7VrQYb/l/11 𝗥𝗲𝗮𝗰𝗵 𝗼𝘂𝘁 𝘁𝗼 𝘂𝘀 𝙎𝙖𝙧𝙩𝙝𝙖𝙠 𝙑𝙖𝙨𝙪𝙙𝙚𝙫𝙖 𝗼𝗿 𝘿𝙧.𝙆.𝘼𝙣𝙖𝙣𝙙 𝙆𝙪𝙢𝙖𝙧 𝘁𝗼 𝘀𝗰𝗵𝗲𝗱𝘂𝗹𝗲 𝗮 𝗺𝗲𝗲𝘁𝗶𝗻𝗴 𝗮𝗻𝗱 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀. 𝗪𝗲 𝗮𝗿𝗲 @ 𝘽𝙤𝙤𝙩𝙝: 323 #WVCDC #WorldVaccineCongress #OneHealth #IIL #IndianImmunologicals #ContractManufacturing #ContractDevelopment

As a prelude to @BioAsiaOfficial 2026, Dr.K.Anand Kumar, MD, Indian Immunologicals ltd hosted a delegation of academic and industry representatives from Australia. The delegation was led by Mary Overington, Trade and Investment Commissioner. Collaborative opportunities were discussed. It is pertinent to note that IIL developed the World’s first vaccine for Tapeworm (Cysvax) in collaboration with the University of Melbourne. IIL also collaborated with Griffith University and developed a live attenuated codon deoptimized vaccine for Covid 19, the work which was published in Nature Communications. IIL also developed a live attenuated vaccine for Zika in collaboration with Griffith University. The clinical trials of this vaccine will be undertaken by Indian Council of Medical Research (@ICMRDELHI). In the evening Dr.K.Anand Kumar participated as a panellist in a session hosted by Mary Overington, Australian Trade and Investment Commission (@Austrade) on the Australia-India collaborative opportunities. The session was moderated by Pushpa Vijayaraghavan. The other panelists included Rakesh Kalapala (@AIGHospitals) and Sarvesh Singh, CEO, Lifesciences and Pharma Telangana. Chakravarthi AVPS, Chairman of the Federation of Pharma Entrepreneurs shared the closing remarks. #BioAsia2026 #LifeSciences #GlobalHealth #ManufacturingExcellence #FOPE #Austrade #Biotech

The 9th IDF International Symposium on Sheep, Goat, Camel & Other Non-Bovine Milk ( @FIL_IDF ) will be organised at Anand, India, from 9–11 February 2026. This global platform will bring together leading researchers, academicians, dairy professionals, milk producers, processors and policymakers to deliberate on the latest science, technology, innovations and policy developments related to non-bovine milks. 🔔 Registration Details Early Bird Registration: Open until 15 January 2026 Regular Registration Closes: 31 January 2026 👉 More information and registration: idfnon-bovine2026.com The three-day symposium will feature in-depth discussions on: 🔹 Socio-economic dimensions 🔹 Animal management – breeding, health & nutrition 🔹 Sustainability and climate responsiveness 🔹 Compositional uniqueness & processing technologies 🔹 Quality, safety & analytical standards 🔹 Therapeutic & functional properties of non-bovine milks Participants will also have the opportunity to join technical tours, explore India’s non-bovine dairy systems, and engage with a global network of experts and institutions working to advance the sector. 📍 Venue: NDDB, Anand, India 🗓 Dates: 9–11 February 2026 Join us in Anand to exchange knowledge, strengthen partnerships, and explore new frontiers in non-bovine dairying. Stay tuned for more updates.

We are participating in @pedicon2026 ! Join us, as we continue our journey of advancing child health with trusted, indigenous vaccines. 📍 Stall No. G18 📅 17–20 January 2026 📍 Biswa Bangla Convention Centre, Kolkata. Let’s come together and shape a healthier future for children. #IIL #NDDB #OneHealth

Dr K Anand Kumar, Managing Director, IIL, met Mr Vijay Nehra, Joint Secretary , Ministry of Health and Family Welfare (@MoHFW_INDIA), and briefed him about the contribution of IIL in nation achieving self sufficiency in the field of vaccines. Other senior persons from IIL - Mr Mukul Gaur, Dr NSN Bhargav, Sr VP, Mr Sarthak Vasudeva, Sr VP were also present. #IIL #NDDB #MOHFW

Indian Immunologicals Limited (IIL) a wholly owned subsidiary of the National Dairy Development Board (@NDDB_Coop) congratulates Dr Meenesh C Shah, Chairman (NDDB and IIL) on his appointment for 3.5 years as Chairman of NDDB by Government of India. His exemplary leadership in the field of dairying, sustainability and organisational excellence will continue to show way in strengthening cooperatives in the world’s largest country for dairying. His compassion and care as Chairman of IIL and Pristine, New Zealand has guided our companies and enabled stay composed and perform exceedingly well during our difficult times. This recognition by Government of India to extend the services of Dr Meenesh C Shah as Chairman of NDDB will also consolidate NDDB and it’s subsidiaries in adding immense value to the nation in realising the dream of Viksit Bharat 2047. #IIL #NDDB

As we step into the New Year, we stand taller—with purpose and responsibility. Because protecting lives is not just our work—it is our pride. At 𝗜𝗻𝗱𝗶𝗮𝗻 𝗜𝗺𝗺𝘂𝗻𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱, we remain committed to vaccine self-sufficiency—empowering India to protect itself and contribute to a healthier world. In 2026, let’s protect more. Reach further. And continue to 𝗜𝗺𝗺𝘂𝗻𝗶𝘇𝗲 𝘄𝗶𝘁𝗵 𝗣𝗿𝗶𝗱𝗲. ✨ 𝗛𝗮𝗽𝗽𝘆 𝗡𝗲𝘄 𝗬𝗲𝗮𝗿 𝟮𝟬𝟮𝟲 ✨ #IIL #OneHealth #NewYear2026

'Isolated Incident': Indian Immunologicals Limited Issues Clarification After Australia's Advisory On Counterfeit Anti-Rabies Vaccine Abhayrab Source: The Free Press Journal | Date: December 27, 2025 Click on the article below to know more: freepressjournal.in/india/isolated…

Abhayrab Controversy: Clarifying the Counterfeit Vaccine Concerns Source: Devdiscourse | Date: December 27, 2025 Click on the article below to know more: devdiscourse.com/article/health…

Fake Rabies Vaccine Advisory Explained: What Australia Warned, What India Clarified Source: NDTV | Date: December 27, 2025 Click on the article below to know more: ndtv.com/health/fake-ra…